Pivotal ECHO Study Provides Reassuring Evidence on HIV Risk and Contraceptives

Press Release: Pivotal ECHO Study Provides Reassuring Evidence on HIV Risk and Contraceptives Durban and New York – Results of a pivotal clinical trial among 7,829 women ages 16-35 in East and Southern Africa provide important evidence to help inform women’s choices...

MEDIA RELEASE – ECHO finds no substantial difference in HIV risk among DMPA-IM, copper IUD, and LNG implant users

MEDIA RELEASE – ECHO finds no substantial difference in HIV risk among DMPA-IM, copper IUD, and LNG implant usersWHO Statement on Depot-medroxyprogesterone acetate (DMPA) A pivotal clinical trial to address a long-standing question about the relationship between...

‘Reassuring’ contraceptives and HIV trial also a wake-up call, experts say

‘Reassuring’ contraceptives and HIV trial also a wake-up call, experts say By Kelli RogersDevex There is no substantial difference in HIV risk among three highly effective methods of contraception, the results of a randomized clinical trial conducted in...

Depo-Provera, an Injectable Contraceptive, Does Not Raise H.I.V. Risk

Depo-Provera, an Injectable Contraceptive, Does Not Raise H.I.V. Risk By Donald G. McNeil Jr.The New York Times The hormone shot — popular among African women who must use birth control in secret — is as safe as other methods, scientists reported.      ...

Hormonal contraception doesn’t increase HIV risk – new study

Hormonal contraception doesn’t increase HIV risk – new study By Vuyo MkizeCity Press It’s been a 30-year wait marked with red flags, speculation and worry but today a new study has answered the question on whether a commonly used hormonal contraceptive...